NorthWest Biotherapeutics Inc (NWBO)

[Nick119]

They cannot update their information as per the journal embargo, which is why the presentation was shared on the secondary website. They cannot acknowledge or discuss the phase 3 trial until the journal has an opportunity to put the information out there 'first'. Once that's done, I expect everything to be be updated, including clinicaltrials.org website with the final findings information.